These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7705605)

  • 1. The CAMP effect of Actinobacillus pleuropneumoniae is caused by Apx toxins.
    Jansen R; Briaire J; Kamp EM; Gielkens AL; Smits MA
    FEMS Microbiol Lett; 1995 Feb; 126(2):139-43. PubMed ID: 7705605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the CAMP phenomenon in Actinobacillus pleuropneumoniae with the RTX toxins ApxI, ApxII and ApxIII.
    Frey J; Kuhn R; Nicolet J
    FEMS Microbiol Lett; 1994 Dec; 124(2):245-51. PubMed ID: 7813893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Actinobacillus pleuropneumonia gene coding for Apx I protein in Escherichia coli.
    Burdychova R; Rychtera M; Horvath R; Dendis M; Bartos M
    FEMS Microbiol Lett; 2004 Jan; 230(1):9-12. PubMed ID: 14734159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation in the LPS outer core biosynthesis gene, galU, affects LPS interaction with the RTX toxins ApxI and ApxII and cytolytic activity of Actinobacillus pleuropneumoniae serotype 1.
    Ramjeet M; Cox AD; Hancock MA; Mourez M; Labrie J; Gottschalk M; Jacques M
    Mol Microbiol; 2008 Oct; 70(1):221-35. PubMed ID: 18713318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinobacillus pleuropneumoniae haemolysin II is secreted from Escherichia coli by A. pleuropneumoniae pleurotoxin secretion gene products.
    Macdonald J; Rycroft AN
    FEMS Microbiol Lett; 1993 May; 109(2-3):317-22. PubMed ID: 8339922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression of a cohemolysin, the CAMP factor of Actinobacillus pleuropneumoniae.
    Frey J; Perrin J; Nicolet J
    Infect Immun; 1989 Jul; 57(7):2050-6. PubMed ID: 2659534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renaturation and purification of ApxII toxin of Actinobacillus pleuropneumoniae.
    Wang C; Liu S; Peng Y; Shao M; Wang Y; Gong Q; Chang Y; Liu J; Liu H; Liu D; Kong X
    Protein Expr Purif; 2007 Apr; 52(2):441-5. PubMed ID: 17218112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth phase mediated regulation of the Actinobacillus pleuropneumoniae ApxI and ApxII toxins.
    Jarma E; Regassa LB
    Microb Pathog; 2004 Apr; 36(4):197-203. PubMed ID: 15001225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaerobiosis, growth phase and Actinobacillus pleuropneumoniae RTX toxin production.
    Jarma E; Corradino G; Regassa LB
    Microb Pathog; 2004 Jul; 37(1):29-33. PubMed ID: 15194157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils.
    Jansen R; Briaire J; Smith HE; Dom P; Haesebrouck F; Kamp EM; Gielkens AL; Smits MA
    Infect Immun; 1995 Jan; 63(1):27-37. PubMed ID: 7806365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae.
    Maier E; Reinhard N; Benz R; Frey J
    Infect Immun; 1996 Nov; 64(11):4415-23. PubMed ID: 8890186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Apx toxins by field strains of Actinobacillus pleuropneumoniae and Actinobacillus suis.
    Kamp EM; Vermeulen TM; Smits MA; Haagsma J
    Infect Immun; 1994 Sep; 62(9):4063-5. PubMed ID: 8063425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the cytotoxic and hemolytic activities of the ApxIIA toxin from Actinobacillus pleuropneumoniae.
    Tu AH; Hausler C; Young R; Struck DK
    Infect Immun; 1994 May; 62(5):2119-21. PubMed ID: 8168980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size.
    Masin J; Fiser R; Linhartova I; Osicka R; Bumba L; Hewlett EL; Benz R; Sebo P
    Infect Immun; 2013 Dec; 81(12):4571-82. PubMed ID: 24082076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RTX toxin genotypes and phenotypes in Actinobacillus pleuropneumoniae field strains.
    Beck M; van den Bosch JF; Jongenelen IM; Loeffen PL; Nielsen R; Nicolet J; Frey J
    J Clin Microbiol; 1994 Nov; 32(11):2749-54. PubMed ID: 7852567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic map of the Actinobacillus pleuropneumoniae RTX-toxin (Apx) operons: characterization of the ApxIII operons.
    Jansen R; Briaire J; van Geel AB; Kamp EM; Gielkens AL; Smits MA
    Infect Immun; 1994 Oct; 62(10):4411-8. PubMed ID: 7927703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of calcium on secretion and activity of the cytolysins of Actinobacillus pleuropneumoniae.
    van Leengoed LA; Dickerson HW
    Infect Immun; 1992 Feb; 60(2):353-9. PubMed ID: 1730467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the Actinobacillus pleuropneumoniae RTX toxin-III gene cluster.
    Chang YF; Shi J; Ma DP; Shin SJ; Lein DH
    DNA Cell Biol; 1993 May; 12(4):351-62. PubMed ID: 8494611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a second hemolysin (HlyII) in Actinobacillus pleuropneumoniae serotype 1 and expression of the gene in Escherichia coli.
    Frey J; van den Bosch H; Segers R; Nicolet J
    Infect Immun; 1992 Apr; 60(4):1671-6. PubMed ID: 1548089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and structural changes of porcine alveolar macrophages induced by sublytic doses of a heat-labile, hemolytic, cytotoxic substance produced by Actinobacillus pleuropneumoniae.
    Tarigan S; Slocombe RF; Browning GF; Kimpton W
    Am J Vet Res; 1994 Nov; 55(11):1548-57. PubMed ID: 7879978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.